date/time interval
- July 1, 2025 - June 30, 2027
Reprogramming of IL-I �Driven Inflammation and Immune Suppression in Breast Cancer and Clonal Hematopoiesis Models Using Targeted Ultrasmall Particle Therapies.
Grant
Overview
awarded by
administered by
sponsor award ID
- MSKCC 254279-01
Affiliation
contributor
- Bradbury, Michelle S. Principal Investigator 2025 - 2027